CERS2 and urinary bladder cancer: Unfortunately, the potential of CERS2 as a predictive biomarker was found to be limited but may have the potential as a therapeutic target for bladder cancer, since the siRNA-mediated downregulation of CERS2 expression resulted in reduced bladder cancer cell migratory potential [90].